Back to
Verition Fund Management LLC
ETON2 quarters
Position history for
Verition Fund Management LLC's holdings in Eton Pharmaceuticals, Inc.
No. Verition exited its ETON (Eton Pharmaceuticals) position in Q2 2025. Its Q1 2025 13F listed 10,189 shares worth $132,253. Verition first reported ETON in Q1 2025 and held it in 1 quarterly 13F filing.
Final Value
$0
Final Shares
0
Total Value Change
-$132,253
Total Shares Change
-10,189
Quarter-by-Quarter History
Other major holders of ETON: BlackRock, Inc., Vanguard Capital Management LLC